Comment
Recently Bartoli et all described a patient with acute hepatic necrosis that occurred two days after treatment with hydrallazine 50 mg daily. The diagnosis was supported by biopsy and rechallenge with the drug. The patient was definitely jaundiced and complained of right upperquadrant pain with nausea and vomiting. We think that our case is important because it provides corroborative evidence of an acute hepatitis-like reaction caused by hydrallazine, in this instance without symptoms. Liver function tests may not routinely be performed during follow-up of patients taking hydrallazine, and the long-term effect of this otherwise unsuspected biochemical disturbance is unknown.
The recent findings of unrecognised hydrazine metabolites in the urine of patients receiving hydrallazine2 indicates a possible aetiology in this case. Hydrazine and acetylhydrazine are known to be involved in hepatotoxic reactions-the latter is thought to be responsible for mediating isoniazid-induced liver damage via microsomal oxidation to a reactive hepatotoxic intermediate.3 Our patient was a rapid acetylator, which may have increased the risk of acetylhydrazineinduced hepatic necrosis, although this is presently disputed in the case of isoniazid.4 Exposure to microsomal enzyme inducers may also increase the risk, although our patient was not exposed to any such drugs. Further evaluation of abnormal liver function tests in asymptomatic patients receiving hydrallazine is indicated. 
Case report
A 57-year-old Caucasian woman was admitted on 3 August 1978 with a five-week history of macroscopic haematuria, fever, and haemoptysis. Before admission she received an injection of corticosteroids. On admission her chest radiograph was normal; serum creatinine was 980 Iamol/l (11 1 mg/ 100 ml) and urinary protein excretion was 1-4 g/day with microscopic haematuria. A renal biopsy was performed on 8 August and haemodialysis started. On 29 August, acute pulmonary distress occurred with severe hypoxaemia (Pao2: 6 kPa (45 mm Hg)) and pulmonary haemorrhages without infection. Bilateral alveolar opacities increased despite ultrafiltration, which induced a hypovolaemic shock. The patient underwent her first plasma exchange and received a pulse of intravenous methylprednisolone (1500 mg) on 1 September. The pulmonary haemorrhages and radiological abnormalities rapidly disappeared. Three other plasma exchanges each removing 3700 ml were performed on 6, 8, and 11 September and combined with prednisone 60 mg/day and cyclophosphamide 125 mg/day. There was, however, no parallel improvement in renal function and regular haemodialysis was required. Three weeks later she developed an extensive pulmonary infection and died.
Pathology-On light microscopy all the glomeruli were necrotic and surrounded by huge epithelial crescents. No acute angiitis was observed. Immunofluorescence showed a diffuse linear fixation of IgG and C3 along the glomerular basement membrane. Intense staining with fibrinogen antiserum was noted in Bowman's space.
Immunological studies-On admission immunological results were: cryoglobulinaemia and Farr assay negative, C3 and C4 normal; no immune complexes were detected using radiolabelled Clq. Radioimmunoassay detected anti-glomerular basement membrane (GBM) antibodies at a slightly positive level (6 %). When pulmonary haemorrhages recurred, anti-GBM antibodies were at the same level (6-9 %). By contrast, circulating immune complexes were raised on 1 September (73 %) and dramatically decreased after the first plasma exchange and bolus of steroids (22 % on 4 September).
On following days they became barely detectable (figure). The Clq assays were performed in triplicate, and the high value on 1 September was confirmed by retesting with new radiolabelled Clq, which gave a result of 66%. 
Comment
Goodpasture's syndrome was suggested by the combination of pulmonary haemorrhages and a crescentic glomerulonephritis with linear and diffuse fixation of IgG along the glomerular basement membrane. In this case relatively low titres of circulating anti-GBM antibodies could have resulted from the assay performed rather late and from the prior administration of steroids.
In the absence of triggering factors, such as infection or hyperhydration, pulmonary haemorrhages were observed to recur simultaneously with a very high level of circulating immune complexes, whereas the level of anti-GBM antibodies did not vary significantly. The treatment strategy combining plasmapheresis, high-dose steroid therapy, and immunosuppressors led to a rapid and definitive disappearance of both pulmonary haemorrhage and circulating immune complexes.
Tung et al2 and more recently Pussell et al3 reported the existence of circulating immune complexes in anti-GBM antibody glomerulonephritis. Other authors have shown that in Goodpasture's syndrome granular deposits could occur after or at the same time as linear IgG deposits, suggesting the presence of superimposed immune complexes.' In addition, the experiments of Brentjens et al5 showed that circulating immune complexes could induce pulmonary lesions. Even though lung biopsy was not performed in our patient, the parallelism between pulmonary involvement and the levels of circulating immune com-plexes suggests their responsibility in the recurrence of pulmonary haemorrhage.
The origin and nature of these immune complexes remain unknown. They may be composed of basal membrane antigens and the corresponding antibodies or they may result from an intercurrent immunological attack of some sort. Our findings emphasise the importance of assaying for immune complexes in patients with Goodpasture's syndrome who suffer recurrences of pulmonary haemorrhages. Haemoperfusion for theophylline overdose Self-poisoning with theophylline is becoming increasingly common, and probably reflects the introduction of sustained-release formulations and their extensive use. Helliwell and Berry' have drawn attention to the serious nature of such overdoses, noting that hypotension, cardiac arrhythmias, and hypokalaemia are associated with a high mortality while tachycardia, nausea, and vomiting, the early features of theophylline intoxication, are not universally present. Indeed, the severity of the overdose may be shown only when convulsions occur, and Zwillich2 has noted that such a presentation carries a 50% mortality. Relatively small overdoses (1-5-4-0 g) from sustainedrelease formulations have caused severe symptoms, whose onset may be delayed up to 10 hours after ingestion. We report here such a patient who was successfully treated by charcoal haemoperfusion.
Case report
A 15-year-old girl (43 kg) who had been prescribed sustained-release theophylline (Phyllocontin) 225 mg twice a day ingested 1-575 g of theophylline (seven tablets) as a result of personal stress. The ingested dose was confirmed by a count of the remaining tablets. Gastric lavage two hours after ingestion produced only a small amount of tablet debris. She remained deceptively well for 10 hours before the sudden onset of hypotension and tachycardia, followed by a cardiorespiratory arrest. After resuscitation she had a profound acidosis, hypokalaemia, and cardiac arrhythmias, notably ventricular tachycardia and supraventricular tachycardia.
The theophylline concentration measured 16 hours after ingestion was 146 mg/l (therapeutic range 5-15 mg/l). In view of this high level, her clinical deterioration, and the onset of frequent convulsions, she was transferred to Guy's Hospital for further management. Haemoperfusion was initiated with a charcoal column (DHP-1 Hydron Haemoperfusion Cartridge, Kuraray Co Ltd, Japan) and continued for three hours, reducing the theophylline level to 31 mg/l. Analysis performed eight hours after the end of haemoperfusion showed that there had been no rebound in the drug level. Her recovery was delayed because of chest complications, including an aspiration pneumonia which had followed the cardiorespiratory arrest. Peritoneal dialysis and then haemodialysis were required for acute renal failure, presumed to be secondary to the profound hypotension.
Comment
There are two American single case reports3 4 of charcoal haemoperfusion being used successfully to manage theophylline overdose In our patient the mean drug clearance was 97 ml/min and the average flow rate through the column 140 ml/min. During 170 minutes of haemoperfusion the venous theophylline concentration was reduced from 120 mg/l to 31 mg/l, and we calculate that 920 mg of theophylline (58% of the stated ingested dose) was cleared from the blood.
This case illustrates the serious nature of theophylline overdose and the value of measuring the plasma concentration early. Relatively small doses, particularly of the sustained-release preparations, seem to produce serious complications. An additional factor may be concurrent therapeutic administration of theophylline, as in our patient. Our results suggest that haemoperfusion may be of value for severely intoxicated patients and should be considered early as a form of treatment in those who show signs of clinical deterioration in association with high plasma concentrations.
We thank the many doctors and nurses who were involved in the care of this patient. 
Anorexia nervosa in diabetes mellitus
Heightened awareness of carbohydrate consumption is a feature of both diabetes mellitus and anorexia nervosa. One authority has noted that the association of these relatively common conditions is surprisingly rare' and we have found only one case reported.' We describe the cases of three insulin-dependent diabetic women who presented to one diabetic clinic with anorexia nervosa. Two patients with a milder condition who refused psychiatric referral were also treated during the same six-month period.
Case reports
(1) The patient developed diabetes when aged 11 years. Difficulties in establishing diabetic control were in part attributed to the fact that the diabetes became a focus of family conflict. The patient rarely tested her urine or co-operated with dietary restrictions. When aged 17 she started to diet. Over six months her weight fell from kg to 40-6 kg (standard weight 54-9 kg) and she ceased menstruating. No physical abnormalities were found and anorexia nervosa was diagnosed. Rapid weight loss did not lead to deterioration in diabetic control. In the psychiatric ward, however, manipulation of the diabetes complicated the management programme. Secret vomiting, refusal to provide urine specimens, and rejection of food after taking insulin all contributed to unexpected severe hypoglycaemic attacks.
